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Abstract 
Unsaturated fatty acids present in the lipids of essential fatty acid (EFA)- 
deficient rats were found to inhibit the oxygenase activity of sheep vesicular gland 
in an instantaneous, reversible manner. However, competitive inhibition by high 
levels of these acids cannot account fully for the reported loss of prostaglandin 
synthetic capacity of these EFA-deficient animals. A similar competitive inhibition 
pattern was observed with several anti-inflammatory drugs tested, whereas others 
also exhibited a time-dependent destructive effect on the oxygenase of the sheep 
vesicular gland. The relative effectiveness of these drugs in treating inflammations 
of the skin paralleled their in vitro effects on the vesicular gland oxygenase . -- 
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INTRODUCTION 
Several investigators have reported that the biosynthesis of prostaglandin 
E2 (PGE2) from arachidonic acid could be inhibited by a variety of fatty acids 
(l-5). Recently, we have also shown that some fatty acids inhibit the biosynthesis 
of PGE2 from arachidonic acid catalyzed by a high speed particulate from human 
skin (6). It was observed that the eicosatrienoic acid 20: 3 (n-3), exerted a 
profound inhibitory effect on the biosynthesis of PGE2 from arachidonic acid in 
the skin. In addition, we have found that different fatty acids present in cellular 
lipids may inhibit the fatty acid oxygenase of sheep vesicular gland in either 
of two distinct patterns; an instantaneous, concentration-dependent, reversible 
effect and a time-dependent non-reversible effect (7). In view of the loss of 
prostaglandin synthesis accompanied by an accumulation of eicosatrienoic acid 20: 3 
(n-9) in the skin of essential fatty acid (EFA)-deficient rats (8), it was of interest 
to ascertain whether this endogenous abnormal fatty acid would inhibit the oxygenase 
in a reversible or irreversible manner. This paper describes the effects of 
eicosatrienoic acid and other unsaturated fatty acids present in the skin of EFA- 
deficient rats on the oxygenase activity of the sheep vesicular gland, the initial 
step in the prostaglandin biosynthetic pathway, and compares them with the effects 
of anti-inflammatory drugs commonly used in the treatment of cutaneous lesions. 
MATERIALS AND METHODS 
Sheep vesicular gland acetone powder was generously donated by the 
Upjohn Company. Triamcinolone acetonide was a gift from E. R. Squibb and 
Sons, Inc., New Brunswick, New Jersey. WP-32 and BL-2338 were provided 
by Dr. Hebborn, Westwood-Pharmaceuticals , Inc., Buffalo, New York, Commercial 
polyunsaturated fatty acids were obtained from the Hormel Institute. Reagents 
were of analytical grade. Deionized water was used for the preparation of all 
solutions. 
The enzyme used in these studies was prepared by homogenizing 50 mg 
of an acetone powder (3) prepared from sheep vesicular gland in 1 ml of 
1 .lM Tris-HCl (pH 8.5) in a small Dounce ball-type homogenizer. Activation 
ofe vesicular gland oxygenase (9) was accomplished by adding O.lM phenol 
to give a final concentration of 0.67 mM and letting the mixture stand at room 
temperature for at least 30 min. beforyuse. 
Oxygen absorption measurement: Oxygen concentrations were measured on 
a Yellow Springs Instrument Company Model 53 oxygen monitor equipped with 
a Model 53 oxygen monitor equipped with a Model 5301 bath assembly. The monitor 
was attached to a Beckman Model 100502 potentiometric recorder and all readings 
were made using the % transmittance setting of the recorder. The oxidation of 
arachidonic acid, 20:4 (n-6), by the phenol-activated oxygenase was determined 
by measuring oxygen absorption at a constant temperature 30° 2 0.5’. In most 
experiments, the total volume of the reaction mixture in the sample chamber was 
3.0 ml (9). Additions of enzyme preparation and various concentrations of 
fatty acids and antiinflammatory agents were made through the side of the 
electrode holder. 
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Isolation and purification of eicosatrienoic acid from skin of 
EFA-deficient rats: Skin specimens were removed from the shaved area 
of the posterior dorsum from six EFA-deficient rats as reported previously 
(8). The skin specimens were minced and homogenized in a mixture of 
chloroform-methanol 2: 1 (lo), with a Polytron (model PTZO) homogenizer. 
The tissue debri was removed by filtration through glass wool. The filtrate 
was evaporated in a rotary evaporator, The total lipids were transesterified 
by refluxing under nitrogen with 60 ml of a 5% solution of HCl in methanol. 
The methyl esters were separated by preparative thin layer chromatography 
on silica gel G. Satisfactory results were obtained by thin layer chromatography 
(0.5 mm) prepared from a slurry of 40g silica gel in 80 ml of 10% AgNO in water. 
Reference fatty acid methyl esters were applied similarly to other plate2 and 
were developed in ether: petroleum ether; benzene (30: 70: 10). The separated 
compounds were visualized after spraying with 0.2% ethanolic dichlorofluorescein 
under ultraviolet light. The silica gel band which corresponded with the 
reference eicosotrienoate was scraped into a sintered funnel, the fatty acid methyl 
ester was eluted with a mixture of chloroform: methanol (1: 1) , and the solvent 
mixture was evaporated to dryness under a stream of nitrogen. The methyl ester 
was analyzed for purity by GLC, using an F and M model 402 with a flame ionization 
detector. Glass columns employed for the isolation of methyl esters of fatty acids 
from EFA-deficient rats were packed with ethylene-glycol-succinate (EGS) 
according to Mohrhauer and Holman (11) or 3% OV-101 silicone copolymer coated 
on Supelcoport, 80-100 mesh (Supelco, Inc., Bellefonte, Pa, > . Authentic methyl 
ester of eicosatrienoic acid (20: 3, n-3) obtained from the Hormel Institute was 
used as an internal standard. 
Further identification of the isolated eicosatrienoic acid was through the plot 
of carbon number against log retention time. The equivalent chain length (ECL) of 
the methyl esters were compared with those published by Hofstetter and Holman 
(12). 
RESULTS AND DISCUSSION 
Previous analysis of fatty acids in the skin of EFA-deficient rats showed 
marked increases in palmitoleic, oleic and (n-9) eicosatrienoic acids in these 
tissues (8). The levels of linoleic and arachidonic acids were correspondingly 
decreased in the skin of these animals. The possibility that the elevation of these 
monoenoic and eicosatrienoic fatty acids could cause the irreversible loss of the 
oxygenase was indicated in the decreased synthesis of prostaglandin E from 
arachidonic acid by skin (8) and also vesicular glands (13) of the EFA2deficient 
rats. The present studies have demonstrated that the eicosatrienoic acid, 20: 3 (n-9) 
isolated from skin of EFA-deficient rats, was not a substrate for the oxygenase 
since no oxygen consumption could be detected in control assays without arachidonate 
20: 4 (n-6). 
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Figure 1. Inhlbltmn of sheep vesicular gland oxygenase by euxsatrwnolc aad, 20 3 
(n-9). The phenol-activated preparatmn (9) was added to mcubation mxtures 
contammg 0. 67 rnx phenol m 0. 1M Tns-HCl buffer pH 8. 5. Immediately after the 
addltmn of “arm”~ amounts of elc%atrlenouz and, 20:3 (n-9), arachldomc ac~d 
(20)1M fmal concentration) was added to the mcubatmn chamber to knItlate the reactmn. 
The reactmn rate was determmed from contmuous measurements of the decreasmg 
oxygen content. The results from several reaction mixtures are superimposed to 
illustrate the data obtamed. A, OpE elcosatrlenolc acld. B. 90 PI, C. 135 MM. 
- 
Figure 1 shows that the oxygenation of arachidonic acid in an in vitro 
system that forms prostaglandins was inhibited by the eicosatrsnzcid, 
20: 3 (n-9). Prolonged incubation of the oxygenase with this acid prior to 
assay with 20: 4 did not result in any appreciable time-dependent destruction 
of the enzymic activity as was seen with other substrate analogs (4) or 
with the substrates themselves (14). A Dixon plot (15) of the data gave an 
estimated K. value for the 20: 3 (n-9) of 20_+10 M. These results indicate 
that the 20: 3 (n-9) fatty acid inhibited the vesicular gland oxygenase in 
an instantaneous, competitive manner. Competitive inhibition constants of 
other unsaturated fatty acids present in EFA-deficinet rats are shown on 
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TABLE I 
INHIBITION OF SHEEP VESICULAR GLAND OXYGENASE BY 
UNSATURATED FATTY ACIDS 
Phenol-activated acetone powder preparatmn of sheep veei- 
cular tissue was added into an assay mixture containing 0.61 + 
phenol III 0.1 g Tris-HCl buffer, pH 8.5. After th? rdditmn of va- 
rious amounts of fatty acids into the incubation mixture, arachldonic 
acid (3-50 pg)was added and the reaction rate (pM/min=nmole/ml 
per mm) determmed from continuous measurements of cxygen uptake 
with the oxygen electrode. 
Competitive inhibition constants of the different unsaturated 
fatty acids were obtained as described in the text. The figures in 
parentheses indicate the number of experunents included. 
FATTY ACID K.+ (PM) 
16:l (n-7) 105 (14) 
18:l (n-9) 22 (19) 
20:3 (n-9) 20 (8) 
20:3 (n-6) 5*(q) 
20:3 (n-3) 6 (19) 
* Smce this acid servea as an efficient substrate for 
the oxygenase, this value represents the apparent 
Km value for the substrate and enzyme. 
Table 1. It can be seen from the data that the inhibitory capacity of 20: 3 
(n-9) is similar to that of 18: 1 (n-9>, with both being better inhibitors than 
16: 1. However, none of these acids was as effective an inhibitor as the 
eicosatrienoic (n-3) isomer, noted in the table. On the other hand, the third 
member of the eicosatrienoic acid family, the (n-6) isomer, is a very 
efficient substrate for the oxygenase and leads to destruction of the enzyme 
(14). 
Accumulation of large amounts of the (n-9) fatty acids in tissues 
deficient in the prostaglandin precursors opened the possibility that such high 
levels may exert an inhibitory effect on any endogenous prostaglandin synthesis 
in these tissues as the combined unsaturated acids are released from ester 
precursors, such as phospholipids (16). However, since the (n-7) and (n-9) 
acids did not cause a progressive loss of the enzyme, their abudance may not fully 
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account for tile reported loss of synthetic actlvlty (R, 13) of the skin from ETA- 
deficient animals . It should be noted that the assays that showed the loss of 
activity were performed in vitro with added unesterified 70: 4 so that the natural 
abundance of inhibitors iKt=terified precursors could not manifest as 
marked an effect as wh en the free acids \\‘ere derived from the esterified pool. 
The effects of various recognized anti-inflammatory agents on the oxidation 
of 20: 3 (n-6) by sheep vesicular gland oxygenase were also examined The 
TABLE II 
Tin EFFECTS OF ANTI-INFLAMMATORY AGENTS ON SHEEP 
VESICULAR GLAND OXYGENASE 
Phenol-activated oxygenas&#was added to an assay mixture 
containmg 0.67 mg phenol and various amounts of the anti-inflam- 
matory agents. After incubation for 1 minute arachldonic acid 
(20 pgfinal concentration) was added and the reaction rate deter- 
mined from continuous measurements of oxygen uptake with an 
oxygen electrode. The [I]5o for each compound 1s the concentration 
of inhibitor that caused 50% inhibition. 
AGENTS Cd 50 PM 
Indomethacin 9.0 




WP-32 1. 1 
concentrations of these compounds that gave 50% inhibition of the oxygenase 
are shown in Table 2. Coldthiomalate and BL-2338, were found to inhibit 
oxygenase activity first in an instantaneous, concentration-dependent manner, 
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and continued pre-incubation of the oxygenase with these compounds, as with 
indomethacin and acetylsalicylic acid resulted in a time-dependent destruction 
of the vesicular gland sheep oxygenase. On the other hand, chloroquine, a 
potent anti-inflammatory agent, and WP-32 inhibited the oxygenase only in an 
instantaneous concentration-dependent manner. It is interesting to note that 
the relative effectiveness of these drugs in treating inflammations of the skin 
(17-19), parallels their in vitro effects with the vesicular gland oxygenase . 
Apparently, there are mTo=ilarities between the fatty acid oxygenase that 
lead to prostaglandin formation in the two tissues. Hydrocortisone and Triamcinolone 
acetonide at concentrations up to 132 M were found not to exert appreciable effects 
on the oxidation of 20: 4 (n-6) by sheep vesicular gland oxygenase. It is unlikely, 
therefore, that the therapeutic effectiveness of these two potent anti-inflammatory 
steroids involve the inhibition of prostaglandin biosynthesis. Other possible 
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